Clinical Trial Update: Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated apixaban to prevent recurrent cancer-related venous thromboembolism in patients who completed initial anticoagulation; results have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Vein Thrombosis
• Deep Vein Thrombosis
• Hematopoietic and Lymphoid Neoplasms
• Malignant Neoplasms
• Malignant Solid Neoplasms
• Pulmonary Embolism
• Splanchnic Vein Thrombosis

Drugs mentioned

• Eliquis (apixaban)

Snippet

Sponsor: Academic and Community Cancer Research United | Conditions: Cerebral Vein Thrombosis, Deep Vein Thrombosis | Phase 3 | Status: COMPLETED | Results posted: 2023-12-12